Literature DB >> 31297913

The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand.

Caroline B Pantazis1, Morgan H James1,2, Brandon S Bentzley3, Gary Aston-Jones1.   

Abstract

Lateral hypothalamus (LH) orexin neuron signaling has been implicated in the motivation to seek and take drugs of abuse. The number of LH orexin neurons has been shown to be upregulated with exposure to drugs of abuse. We sought to determine if the number of LH orexin neurons related to individual differences in motivation (demand) for cocaine in our behavioral economics (BE) paradigm, and whether knockdown of these cells predicted changes in economic demand. We quantified LH orexin cell numbers in animals immediately following our BE paradigm, as well as after a 2-week period of abstinence, to relate the number of LH orexin cells to economic demand for cocaine. We also knocked down LH orexin expression with an orexin morpholino antisense to determine how reduced orexin numbers impacted cocaine demand. We found that animals with greater baseline motivation for cocaine (lower demand elasticity) had more LH orexin neurons. Following a 2-week abstinence from cocaine, the number of LH orexin neurons predicted economic demand for cocaine prior to abstinence, indicating that orexin expression is a persistent marker for demand. Reducing LH orexin cell numbers with antisense decreased motivation for cocaine (increased demand elasticity) without affecting baseline consumption. In addition, the number of spared LH orexin neurons after antisense treatment correlated with individual motivation for cocaine. These studies point to a role for the endogenous number of LH orexin neurons in individual differences in motivation for cocaine.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  behavioral economics; hypothalamus; motivation

Mesh:

Substances:

Year:  2019        PMID: 31297913      PMCID: PMC7083199          DOI: 10.1111/adb.12795

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  47 in total

Review 1.  Arousal and reward: a dichotomy in orexin function.

Authors:  Glenda C Harris; Gary Aston-Jones
Journal:  Trends Neurosci       Date:  2006-08-14       Impact factor: 13.837

2.  Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats.

Authors:  Morgan H James; Colin M Stopper; Benjamin A Zimmer; Nikki E Koll; Hannah E Bowrey; Gary Aston-Jones
Journal:  Biol Psychiatry       Date:  2018-08-07       Impact factor: 13.382

3.  The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice.

Authors:  Marcelo F Lopez; David E Moorman; Gary Aston-Jones; Howard C Becker
Journal:  Brain Res       Date:  2016-02-04       Impact factor: 3.252

4.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

Authors:  L de Lecea; T S Kilduff; C Peyron; X Gao; P E Foye; P E Danielson; C Fukuhara; E L Battenberg; V T Gautvik; F S Bartlett; W N Frankel; A N van den Pol; F E Bloom; K M Gautvik; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

5.  Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.

Authors:  Stephen V Mahler; Rachel J Smith; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2012-03-13       Impact factor: 4.530

6.  Use of vivo-morpholinos for control of protein expression in the adult rat brain.

Authors:  Kathryn J Reissner; Gregory C Sartor; Elena M Vazey; Thomas E Dunn; Gary Aston-Jones; Peter W Kalivas
Journal:  J Neurosci Methods       Date:  2011-10-17       Impact factor: 2.390

7.  A role for lateral hypothalamic orexin neurons in reward seeking.

Authors:  Glenda C Harris; Mathieu Wimmer; Gary Aston-Jones
Journal:  Nature       Date:  2005-08-14       Impact factor: 49.962

8.  Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol--preferring Sprague--Dawley rats.

Authors:  David E Moorman; Gary Aston-Jones
Journal:  Alcohol       Date:  2009-08       Impact factor: 2.405

9.  Hypocretin/orexin deficiency decreases cocaine abuse liability.

Authors:  Nadia Steiner; Clara Rossetti; Takeshi Sakurai; Masashi Yanagisawa; Luis de Lecea; Pierre J Magistretti; Olivier Halfon; Benjamin Boutrel
Journal:  Neuropharmacology       Date:  2018-02-15       Impact factor: 5.250

10.  Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area.

Authors:  J Antonio González; Lise T Jensen; Lars Fugger; Denis Burdakov
Journal:  Eur J Neurosci       Date:  2012-04-16       Impact factor: 3.386

View more
  18 in total

1.  Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Neuropharmacology       Date:  2019-12-04       Impact factor: 5.250

2.  Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil.

Authors:  Aida Mohammadkhani; Jennifer E Fragale; Caroline B Pantazis; Hannah E Bowrey; Morgan H James; Gary Aston-Jones
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

3.  Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?"

Authors:  Morgan H James; Gary Aston-Jones
Journal:  Brain Res       Date:  2020-01-10       Impact factor: 3.252

4.  The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.

Authors:  Joost Wiskerke; Morgan H James; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-04-16       Impact factor: 3.252

Review 5.  New directions in modelling dysregulated reward seeking for food and drugs.

Authors:  Robyn M Brown; Christopher V Dayas; Morgan H James; Rachel J Smith
Journal:  Neurosci Biobehav Rev       Date:  2021-11-02       Impact factor: 8.989

6.  Reduction of Orexin-A Is Associated With Anxiety and the Level of Depression of Male Methamphetamine Users During the Initial Withdrawal Period.

Authors:  Lei Guo; Aqian Hu; Xiaoxi Zhao; Xiaojun Xiang
Journal:  Front Psychiatry       Date:  2022-07-04       Impact factor: 5.435

Review 7.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

8.  Involvement of orexin/hypocretin in the expression of social play behaviour in juvenile rats.

Authors:  Christina J Reppucci; Cassandra K Gergely; Remco Bredewold; Alexa H Veenema
Journal:  Int J Play       Date:  2020-02-09

9.  Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system.

Authors:  Jennifer E Fragale; Morgan H James; Gary Aston-Jones
Journal:  Addict Biol       Date:  2020-08-14       Impact factor: 4.280

10.  Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.

Authors:  Aida Mohammadkhani; Morgan H James; Caroline B Pantazis; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-09-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.